Business · 01/10/2012
FDA Releases Guidance on Developing Antimicrobial Drugs for COPD Patients
The FDA has released a guidance for industry on developing antimicrobial drugs to treat acute bacterial exacerbations of chronic bronchitis in patients with chronic obstructive pulmonary disease (COPD).